Cumberland Pharmaceuticals Inc.CPIXNASDAQ

Revenue (LTM)

$45M

+17.6% YoY

Net Income (LTM)

$-3M

+56.2% YoY

Free Cash Flow

$5M

Revenue CAGR (5Y)

+3.5%

Marginsimproving

FCFTurned positive

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	36	42↑16.7%	40↓5.9%	38↓4.3%	45↑17.6%
Gross Profit	27	33↑21.0%	33↑1.8%	31↓6.6%	38↑21.0%
Operating Income	-8	-6↑25.7%	-10↓67.5%	-6↑32.7%	-3↑56.6%
Net Income	-4	-6↓58.8%	-6↓12.7%	-6↓3.2%	-3↑56.2%
EBITDA	-1	0↑138.8%	2↑646.6%	0↓92.7%	2↑1267.1%
EPS Diluted	-0.24	-0.38↓58.3%	-0.44↓15.8%	-0.46↓4.5%	-0.19↑58.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	27	20↓26.9%	18↓7.3%	18↓2.0%	11↓36.3%
Total Current Assets	46	46↑0.4%	36↓22.1%	36↑2.1%	37↑1.7%
Total Assets	84	93↑10.0%	82↓12.0%	76↓7.6%	77↑1.6%
Total Current Liabilities	19	29↑48.2%	28↓2.1%	32↑13.0%	37↑16.2%
Total Liabilities	42	57↑36.1%	53↓7.8%	53↑1.0%	52↓1.4%
Total Equity	43	36↓15.3%	30↓18.4%	23↓22.8%	25↑8.9%
Total Debt	16	21↑30.5%	18↓12.1%	21↑11.6%	10↓50.5%
Net Debt	-11	1↑110.9%	0↓91.1%	3↑2340.8%	-1↓148.5%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	6	8↑33.3%	6↓27.9%	-1↓110.0%	5↑905.7%
Capital Expenditure	-0	-2↓485.1%	-0↑78.2%	-0↑60.3%	-0↑45.5%
Free Cash Flow	6	6↑6.5%	6↓11.6%	-1↓114.0%	5↑710.5%
Stock-Based Comp	1	0↓39.7%	0↓18.4%	0↓17.3%	0
Net Change in Cash	2	-7↓418.4%	-1↑80.3%	-0↑75.1%	-7↓1723.9%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance